Thermo Fisher continues to invest in pharma services capabilities in 2026
The company is strengthening development and manufacturing offerings, says Anil Kane, global head of technical and scientific affairs for Thermo Fisher’s pharma services.
Read the full article on the original site.
Read Full Article